Jeremy G Chadwick sold $9.0M of Kymera Therapeutics (KYMR)

Executed Mar 23, disclosed Mar 25, 2 days later.

Value, as filed

$9.0M

114,777 sh across 5 lots

Executed

Mar 23

the trade date, as filed

Disclosed

Mar 25

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jeremy G Chadwick Chief Operating Officer profile →

Jeremy G Chadwick (Chief Operating Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $9.0M of KYMR (114,777 sh across 5 lots, as filed), executed Mar 23.

The name

KYMR

Kymera Therapeutics, Inc. KYMR · Healthcare · 58 filings in 24 months ticker →

Healthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jeremy G Chadwick in KYMR

KYMRSALE Kymera Therapeutics, Inc. $1.3M
15,709 sh across 4 lots
Exec May 26
Filed May 27 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $590K
6,551 sh across 2 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $1.8M
21,140 sh across 2 lots
Exec Mar 31
Filed Apr 1 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $2.1M
25,758 sh across 3 lots
Exec Mar 11
Filed Mar 11 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $172K
2,017 sh × $85.04
Exec Mar 4
Filed Mar 4 · 5:30 PM ET